HealthUnited States1 sourcesNeutral

GI Innovation to Present Phase 1 Immunotherapy Data at ASCO 2026

GI Innovation will present Phase 1 clinical data for its immuno-oncology drug GI-101A in an oral presentation at ASCO 2026 in Chicago, highlighting its clinical potential and combination therapy value.

park hyo-jeong

via 서울경제

April 3, 2026 | 5:47 AM UTCUpdated 3h ago

Share Read original

Read the full article at 서울경제 →

GI Innovation to Present Phase 1 Immunotherapy Data at ASCO 2026

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

서울경제

NewsDataUS

Comments

0 comments

Be respectful and constructive.

Loading comments...

NASA’s Artemis II Cleared for Moon Flight As Orion Prepares for Critical Engine Burn

Health

As Israel’s PTSD crisis deepens, new treatment offers hope for scarred IDF veterans

Toby Klein Greenwald-1h ago-1 sources

Health

The 'sweetest' Surrey dog who has been left waiting 17 months for a forever home

Surrey Live-15h ago-1 sources

Health

Coronation Street legend Ashley Peacock speaks out on potential return to the cobbles

Chesterstandard Co Uk-15h ago-1 sources

GI Innovation to Present Phase 1 Immunotherapy Data at ASCO 2026

Source Verification

Comments

NASA’s Artemis II Cleared for Moon Flight As Orion Prepares for Critical Engine Burn

Calcutta High Court says BSF could have reclaimed salary after man serves as constable for 32 years on fake papers

Related Articles

As Israel’s PTSD crisis deepens, new treatment offers hope for scarred IDF veterans

The 'sweetest' Surrey dog who has been left waiting 17 months for a forever home

Coronation Street legend Ashley Peacock speaks out on potential return to the cobbles